XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of fair value of financial assets and liabilities
                    
       Fair Value Measurements at December 31, 2022 Using 
   Fair Value at
December 31,
2022
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Cash and cash equivalents  $220,645   $220,645   $   $ 
Total assets  $220,645   $220,645   $   $ 
                     
Liabilities:                    
Anti-dilution issuance rights derivative liability  $46,700   $   $   $46,700 
Total liabilities  $46,700   $   $   $46,700 

 

       Fair Value Measurements at December 31, 2021 Using 
   Fair Value at
December 31,
2021
   Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
   Significant Other
Observable
Inputs
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Assets:                    
Cash and cash equivalents  $226,142   $226,142   $   $ 
Total assets  $226,142   $226,142   $   $ 
                     
Liabilities:                    
Anti-dilution issuance rights derivative liability  $104,300   $   $   $104,300 
Total liabilities  $104,300   $   $   $104,300 
Schedule of assumptions used
          
  

December 31,

2022

  

December 31,

2021

 
Fair value of common stock (per share)  $0.99   $1.02 
Estimated additional shares of common stock   71,511    134,229 
Expected volatility   130%    105% 
Expected term (years)   0.25    0.25 
Risk-free interest rate   4.42%    0.06%